CD8+ T Cell Imaging During Pre-surgery Immunotherapy in People With Melanoma
Status:
Recruiting
Trial end date:
2024-03-11
Target enrollment:
Participant gender:
Summary
Combination treatment with nivolumab and ipilimumab before surgery may help people with
melanoma because the drugs are designed to help the immune system target and destroy cancer
cells (immunotherapy), which may shrink the cancer. Treatment given before surgery is called
neoadjuvant therapy. The purpose of this study is to find out whether neoadjuvant therapy
with nivolumab and ipilimumab can reduce tumor size by destroying parts of the tumor before
surgery and prevent disease from coming back after surgery